Trial Information

Status:

Open

Specialty:

Lung

Date Opened:

28/03/2023

Planned Close date:

31/03/2027

Sponsors:

Merck KGaA Headquaters- Germany

Site Recruitment:

7 /

5

Principal Investigator:

Dr Amin Ali

Study Title:

MOMENT (Met nOn sMall cEll caNcer regisTry)

Contacts

Research Nurse / Study Coordinator:

Zainab Chauhan

Administrator:

-

Disease Registry on Patients with Advanced Non-small Cell Lung Cancer (NSCLC) Harboring METex14 Skipping Alterations / MOMENT ((Met nOn sMall cEll caNcer regisTry))

Patients who have advanced non-small cell lung cancer (NSCLC) with the genetic defect called ‘METex14 skipping alterations’ and are being treated with currently approved anti-cancer therapies can be included in the registry.

-

-